These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20976704)

  • 21. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery.
    Chen Y; Chen H; Zeng D; Tian Y; Chen F; Feng J; Shi J
    ACS Nano; 2010 Oct; 4(10):6001-13. PubMed ID: 20815402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs.
    Sezgin Z; Yüksel N; Baykara T
    Eur J Pharm Biopharm; 2006 Nov; 64(3):261-8. PubMed ID: 16884896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability.
    Paillard A; Hindré F; Vignes-Colombeix C; Benoit JP; Garcion E
    Biomaterials; 2010 Oct; 31(29):7542-54. PubMed ID: 20630585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic honokiol delivery: I. Preparation and characterization.
    Gong C; Wei X; Wang X; Wang Y; Guo G; Mao Y; Luo F; Qian Z
    Nanotechnology; 2010 May; 21(21):215103. PubMed ID: 20431208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles.
    Cho YW; Lee J; Lee SC; Huh KM; Park K
    J Control Release; 2004 Jun; 97(2):249-57. PubMed ID: 15196752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs.
    Lukyanov AN; Torchilin VP
    Adv Drug Deliv Rev; 2004 May; 56(9):1273-89. PubMed ID: 15109769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PEGylated polypeptide lipid nanocapsules to enhance the anticancer efficacy of erlotinib in non-small cell lung cancer.
    Kim J; Ramasamy T; Choi JY; Kim ST; Youn YS; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2017 Feb; 150():393-401. PubMed ID: 27825759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response.
    Cosco D; Paolino D; De Angelis F; Cilurzo F; Celia C; Di Marzio L; Russo D; Tsapis N; Fattal E; Fresta M
    Eur J Pharm Biopharm; 2015 Jan; 89():30-9. PubMed ID: 25460850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
    Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
    Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid nanocapsules: a new platform for nanomedicine.
    Huynh NT; Passirani C; Saulnier P; Benoit JP
    Int J Pharm; 2009 Sep; 379(2):201-9. PubMed ID: 19409468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.
    Talelli M; Iman M; Varkouhi AK; Rijcken CJ; Schiffelers RM; Etrych T; Ulbrich K; van Nostrum CF; Lammers T; Storm G; Hennink WE
    Biomaterials; 2010 Oct; 31(30):7797-804. PubMed ID: 20673684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells.
    Hu Y; Xie J; Tong YW; Wang CH
    J Control Release; 2007 Mar; 118(1):7-17. PubMed ID: 17241684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of pluronic and PEG-PE micelles as carriers of meso-tetraphenyl porphine for oral administration.
    Sezgin Z; Yuksel N; Baykara T
    Int J Pharm; 2007 Mar; 332(1-2):161-7. PubMed ID: 17055200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A tumor vasculature targeted liposome delivery system for combretastatin A4: design, characterization, and in vitro evaluation.
    Nallamothu R; Wood GC; Pattillo CB; Scott RC; Kiani MF; Moore BM; Thoma LA
    AAPS PharmSciTech; 2006 Apr; 7(2):E32. PubMed ID: 16796350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles.
    Seow WY; Xue JM; Yang YY
    Biomaterials; 2007 Mar; 28(9):1730-40. PubMed ID: 17182095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Core-cross-linked polymeric micelles as paclitaxel carriers.
    Shuai X; Merdan T; Schaper AK; Xi F; Kissel T
    Bioconjug Chem; 2004; 15(3):441-8. PubMed ID: 15149170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo evaluation of paclitaxel-loaded lipid nanocapsules after intravenous and oral administration on resistant tumor.
    Groo AC; Bossiere M; Trichard L; Legras P; Benoit JP; Lagarce F
    Nanomedicine (Lond); 2015 Mar; 10(4):589-601. PubMed ID: 25723092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro drug release mechanism from lipid nanocapsules (LNC).
    Abdel-Mottaleb MM; Neumann D; Lamprecht A
    Int J Pharm; 2010 May; 390(2):208-13. PubMed ID: 20149853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells.
    Mai J; Song S; Rui M; Liu D; Ding Q; Peng J; Xu Y
    J Control Release; 2009 Nov; 139(3):174-81. PubMed ID: 19576253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Out-of-the-Box Nanocapsules Packed with On-Demand Hydrophobic Anticancer Drugs for Lung Targeting, Esterase Triggering, and Synergy Therapy.
    Zhao D; Jiang K; Wang Y; Cheng J; Mo F; Luo T; Guo Y; Zhang C; Song J
    Adv Healthc Mater; 2021 Apr; 10(8):e2001803. PubMed ID: 33433961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.